| Group A | Group B | Genotype (A+B) | Group C | Group D | Infection (C+D) | Total on array |
---|---|---|---|---|---|---|---|
Acute-phase response | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 13 (59%) | 13 (59%) | 22 |
Antigen presentation | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 23 (72%) | 23 (72%) | 32 |
Apoptosis | 0 (0%) | 3 (1%) | 3 (1%) | 9 (3%) | 50 (15%) | 59 (18%) | 324 |
Cell cycle | 0 (0%) | 1 (0%) | 1 (0%) | 30 (6%) | 59 (12%) | 89 (17%) | 510 |
Chemokine Activity | 0 (0%) | 0 (0%) | 0 (0%) | 1 (3%) | 24 (67%) | 25 (69%) | 36 |
Mus musculus 12 a | 12 (2%) | 11 (2%) | 23 (4%) | 34 (6%) | 38 (7%) | 72 (13%) | 560 |
   Bps-1 (Mus musculus 12) | 8 (4%) | 9 (5%) | 17 (9%) | 6 (3%) | 8 (4%) | 14 (8%) | 185 |
Complement activation | 0 (0%) | 1 (3%) | 1 (3%) | 1 (3%) | 8 (26%) | 9 (29%) | 31 |
Cytokine Activity | 0 (0%) | 0 (0%) | 0 (0%) | 8 (4%) | 56 (29%) | 64 (33%) | 192 |
Cytoskeleton | 0 (0%) | 2 (0%) | 2 (0%) | 48 (9%) | 45 (8%) | 93 (18%) | 531 |
Development | 5 (0%) | 9 (1%) | 14 (1%) | 137 (10%) | 118 (8%) | 255 (18%) | 1433 |
Immune response | 1 (0%) | 2 (0%) | 3 (1%) | 6 (1%) | 176 (43%) | 182 (45%) | 408 |
Inflammatory response | 0 (0%) | 1 (1%) | 1 (1%) | 5 (4%) | 52 (43%) | 57 (47%) | 121 |
Metabolism | 3 (0%) | 20 (0%) | 23 (0%) | 300 (6%) | 405 (8%) | 705 (15%) | 4771 |
Muscle contraction | 0 (0%) | 0 (0%) | 0 (0%) | 14 (29%) | 2 (4%) | 16 (33%) | 49 |
Listed in any of the above | 19 | 29 | 48 | 453 | 656 | 1109 | 6574 |
Other | 3 | 22 | 25 | 383 | 513 | 896 | 5639 |
Unannotated | 85 | 48 | 133 | 127 | 221 | 348 | 9744 |
Total | 107 | 99 | 206 | 963 | 1390 | 2353 | 21957 |